Dexmedetomidine promotes the progression of hepatocellular carcinoma through hepatic stellate cell activation

Dexmedetomidine (DEX) is an anesthetic that is widely used in the clinic, and it has been reported to exhibit paradoxical effects in the progression of multiple solid tumors. In this study, we sought to explore the mechanism by which DEX regulates hepatocellular carcinoma (HCC) progression underlyin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Exp Mol Med
Main Authors: Chen, Peng, Luo, Xiaojun, Dai, Guanqi, Jiang, Yuchuan, Luo, Yue, Peng, Shuang, Wang, Hao, Xie, Penghui, Qu, Chen, Lin, Wenyu, Hong, Jian, Ning, Xue, Li, Aimin
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8080602/
https://ncbi.nlm.nih.gov/pubmed/32632241
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s12276-020-0461-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados